Finance

Lists
GSK:BCBA
Glaxosmithkline CEDEAR
၂၀,၉၅၀.၀၀ ARS
-၀.၁၉%
(-၄၀.၀၀) 1D
နို ၁၁, GMT-၃ ၁၁:၁၈:၀၂  ·   ARS
All symbols
SymbolPriceChange% Change
Generating top insights for GSK...
Open
၂၀,၉၅၀.၀၀ ARS
High
၂၀,၉၅၀.၀၀ ARS
Low
၂၀,၉၅၀.၀၀ ARS
Mkt. cap
ဋေ ၉.၉၆ ထ
Avg. vol.
၀.၀၀
Volume
၁.၀၀
52-wk high
၂၂,၇၆၀.၀၀ ARS
52-wk low
၁၇,၀၁၀.၀၀ ARS
Shares outstanding
၄၀၄.၅၄ ဋေ
No. of employees
၇ သောင်း
Open
၂၀,၉၅၀.၀၀ ARS
High
၂၀,၉၅၀.၀၀ ARS
Low
၂၀,၉၅၀.၀၀ ARS
Mkt. cap
ဋေ ၉.၉၆ ထ
Avg. vol.
၀.၀၀
Volume
၁.၀၀
52-wk high
၂၂,၇၆၀.၀၀ ARS
52-wk low
၁၇,၀၁၀.၀၀ ARS
Shares outstanding
၄၀၄.၅၄ ဋေ
No. of employees
၇ သောင်း
News stories
From web sources and news partners
Traders Union
Traders Union
·
ပြီးခဲ့သည့် ၇ နာရီ
Will GSK stock maintain its range-bound trend as buyers defend support?
JournalArta
JournalArta
·
ပြီးခဲ့သည့် ၁၁ နာရီ
GSK Share Price: 1,917.0p, Up 0.66% Nov 10
JournalArta
JournalArta
·
ပြီးခဲ့သည့် ၁ ရက်
GSK Share Price: 1,904.5p, Up 0.77% Nov 9
JournalArta
JournalArta
·
ပြီးခဲ့သည့် ၂ ရက်
GSK Share Price: 1,890.0p, Up 0.00% Nov 6
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK. The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About Glaxosmithkline CEDEAR
CEOEmma Walmsley | Emma Walmsley
Employees၆.၆၈ သောင်း
Founded၂၀၀၀ ဒီ ၂၇
Headquarters-
SectorHealth Care
Industry-
Websitegsk.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၈၆၁.၈၀ ဋေ
၇၆၂.၉၀ ဋေ
၈၄၀.၉၀ ဋေ
၈၈၈.၇၀ ဋေ
Cost of goods sold
၂၆၁.၇၀ ဋေ
၁၈၇.၃၀ ဋေ
၂၀၇.၂၀ ဋေ
၂၂၄.၀၀ ဋေ
Cost of revenue
၂၆၁.၇၀ ဋေ
၁၈၇.၃၀ ဋေ
၂၀၇.၂၀ ဋေ
၂၂၄.၀၀ ဋေ
Research and development expenses
၂၁၃.၈၀ ဋေ
၁၅၁.၈၀ ဋေ
၁၇၄.၇၀ ဋေ
၁၉၀.၄၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၆၆.၆၀ ဋေ
၂၀၈.၅၀ ဋေ
၂၁၉.၂၀ ဋေ
၂၁၇.၄၀ ဋေ
Operating expense
၄၃၇.၀၀ ဋေ
၂၉၈.၈၀ ဋေ
၃၇၃.၅၀ ဋေ
၄၀၆.၁၀ ဋေ
Total operating expenses
၆၉၈.၇၀ ဋေ
၄၈၆.၁၀ ဋေ
၅၈၀.၇၀ ဋေ
၆၃၀.၁၀ ဋေ
Operating income
၁၆၃.၁၀ ဋေ
၂၇၆.၈၀ ဋေ
၂၆၀.၂၀ ဋေ
၂၅၈.၆၀ ဋေ
Other non operating income
-၂.၁၀ ကုဋေ
-
-
-
EBT including unusual items
၉၅.၀၀ ကုဋေ
၂၁၄.၄၀ ဋေ
၃၅.၄၀ ကုဋေ
၁၉၃.၅၀ ဋေ
EBT excluding unusual items
၁၄၈.၁၀ ဋေ
၂၆၁.၉၀ ဋေ
၂၄၇.၅၀ ဋေ
၂၃၉.၄၀ ဋေ
Income tax expense
၂၂.၃၀ ကုဋေ
၃၀.၅၀ ကုဋေ
-၁၉.၉၀ ကုဋေ
၂၃.၂၀ ကုဋေ
Effective tax rate
၂၃.၄၇%
၁၄.၂၃%
-၅၆.၂၁%
၁၁.၉၉%
Other operating expenses
-၄၃.၄၀ ကုဋေ
-၆၁.၅၀ ကုဋေ
-၂၀.၄၀ ကုဋေ
-၁.၇၀ ကုဋေ
Net income
၆၃.၆၀ ကုဋေ
၁၇၃.၇၀ ဋေ
၄၃.၅၀ ကုဋေ
၁၅၄.၃၀ ဋေ
Net profit margin
၇.၃၈%
၂၂.၇၇%
၅.၁၇%
၁၇.၃၆%
Earnings per share
-
-
-
-
Interest and investment income
၁.၇၀ ကုဋေ
၂.၂၀ ကုဋေ
၅.၈၀ ကုဋေ
၂.၉၀ ကုဋေ
Interest expense
-၁၄.၅၀ ကုဋေ
-၁၆.၇၀ ကုဋေ
-၁၈.၂၀ ကုဋေ
-၂၁.၉၀ ကုဋေ
Net interest expenses
-၁၂.၈၀ ကုဋေ
-၁၄.၅၀ ကုဋေ
-၁၂.၄၀ ကုဋေ
-၁၉.၀၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၂၆၈.၉၀ ဋေ
၃၂၃.၁၀ ဋေ
၂၈၂.၅၀ ဋေ
၃၃၂.၇၀ ဋေ
Gain or loss from assets sale
-၄.၀၀ ကုဋေ
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ